Ostéodensitométrie [absorptiométrie osseuse] sur 2 sites, par méthode biphotonique. Mis à jour le 21 juin, 2006. ,
relative à la politique de santé publique, Journal Officiel, vol.11, 2004. ,
Epidemiology and outcomes of osteoporotic fractures, The Lancet, vol.359, issue.9319, pp.1761-1768, 2002. ,
DOI : 10.1016/S0140-6736(02)08657-9
Epidemiology of osteoporosis, Best Practice & Research Clinical Endocrinology & Metabolism, vol.22, issue.5, pp.671-85, 2008. ,
DOI : 10.1016/j.beem.2008.06.001
Physiopathologie de l'ost??oporose, La Revue de M??decine Interne, vol.25, pp.531-538, 2004. ,
DOI : 10.1016/S0248-8663(04)80051-1
Histologie humaine De Boeck Supérieur, pp.234-278, 1997. ,
Innovations th??rapeutiques dans l???ost??oporose (anticorps antiscl??rostine et denosumab), Annales d'Endocrinologie, vol.72, pp.15-22, 2011. ,
DOI : 10.1016/S0003-4266(11)70005-1
Osteoporosis: now and the future, The Lancet, vol.377, issue.9773, pp.1276-87, 2011. ,
DOI : 10.1016/S0140-6736(10)62349-5
Acquisition de la masse osseuse chez l???enfant : physiopathologie et ??valuation, Archives de P??diatrie, vol.16, issue.6, pp.591-594, 2009. ,
DOI : 10.1016/S0929-693X(09)74078-3
G??n??tique et m??tabolisme osseux, Revue du Rhumatisme Monographies, vol.77, issue.4, pp.307-320, 2010. ,
DOI : 10.1016/j.monrhu.2010.07.002
Physiopathologie de l'ost??oporose. Cons??quences biom??caniques axiales de l'ost??op??nie et des modifications architecturales, Annales de R??adaptation et de M??decine Physique, vol.38, issue.5, pp.259-63, 1995. ,
DOI : 10.1016/0168-6054(96)89326-3
Impact of genetic variation on metabolic response of bone to diet, Proceedings of the Nutrition Society, vol.60, issue.04, pp.901-913, 2003. ,
DOI : 10.1002/jbmr.5650110304
New treatment targets in osteoporosis, Joint Bone Spine, vol.77, issue.3, pp.222-230, 2010. ,
DOI : 10.1016/j.jbspin.2010.02.004
Alterations of Cortical and Trabecular Architecture Are Associated With Fractures in Postmenopausal Women, Partially Independent of Decreased BMD Measured by DXA: The OFELY Study, Journal of Bone and Mineral Research, vol.312, issue.3, pp.425-458, 2007. ,
DOI : 10.1359/jbmr.061206
Epidemiology of osteoporosis-related fractures in France: A literature review, Joint Bone Spine, vol.77, issue.6, pp.546-51, 2010. ,
DOI : 10.1016/j.jbspin.2010.02.006
An estimate of the worldwide prevalence and disability associated with osteoporotic fractures, Osteoporosis International, vol.16, issue.suppl 2, pp.1726-1759, 2006. ,
DOI : 10.1007/s00198-006-0172-4
Incidence and cost of osteoporotic fractures in France during 2001. A methodological approach by the national hospital database, Osteoporosis International, vol.13, issue.12, pp.1475-80, 2005. ,
DOI : 10.1007/s00198-005-2031-0
Mortality Risk Associated With Low-Trauma Osteoporotic Fracture and Subsequent Fracture in Men and Women, JAMA, vol.301, issue.5, pp.513-534, 2009. ,
DOI : 10.1001/jama.2009.50
??pid??miologie et facteurs de risque d' ost??oporose, La Revue de M??decine Interne, vol.25, pp.517-542, 2004. ,
DOI : 10.1016/S0248-8663(04)80049-3
Prevalence of vertebral fractures in French women older than 75 years from the EPIDOS study, Bone, vol.34, issue.2, pp.362-369, 2004. ,
DOI : 10.1016/j.bone.2003.11.008
Population-Based Study of Survival after Osteoporotic Fractures, American Journal of Epidemiology, vol.137, issue.9, pp.1001-1006, 1993. ,
DOI : 10.1093/oxfordjournals.aje.a116756
Prévention, diagnostic et traitement de l'ostéoporose. Mis à jour en juillet, 2006. ,
L'ost??oporose??: aujourd'hui et??demain, Revue du Rhumatisme, vol.73, issue.8, pp.791-795, 2006. ,
DOI : 10.1016/j.rhum.2006.06.001
Epidemiology of falls and fall-related injuries in the aged, Rev Epidemiol Sante Publique, vol.43, pp.72-83, 1995. ,
Fall-related factors and risk of hip fracture: the EPIDOS prospective study, The Lancet, vol.348, issue.9021, pp.145-154, 1996. ,
DOI : 10.1016/S0140-6736(96)01440-7
2012 update of French guidelines for the pharmacological treatment of postmenopausal osteoporosis, Joint Bone Spine, vol.79, issue.3, pp.304-317, 2012. ,
DOI : 10.1016/j.jbspin.2012.02.014
Osteoporosis in otherwise healthy perimenopausal and early postmenopausal women: Physical and biochemical characteristics, Osteoporosis International, vol.68, issue.2, pp.193-200, 2006. ,
DOI : 10.1007/s00198-005-1954-9
Yield of Laboratory Testing to Identify Secondary Contributors to Osteoporosis in Otherwise Healthy Women, The Journal of Clinical Endocrinology & Metabolism, vol.87, issue.10, pp.4431-4438, 2002. ,
DOI : 10.1210/jc.2002-020275
Ost??oporose postm??nopausique??: quand faut-il demander un bilan biologique??? En quoi consiste-t-il???, Gyn??cologie Obst??trique & Fertilit??, vol.36, issue.6, pp.656-664, 2008. ,
DOI : 10.1016/j.gyobfe.2008.04.005
Bone turnover markers for osteoporotic status assessment? A systematic review of their diagnosis value at baseline in osteoporosis, Joint Bone Spine, vol.79, issue.1, pp.20-25, 2012. ,
DOI : 10.1016/j.jbspin.2011.05.003
Prognostic interest of bone turnover markers in the management of postmenopausal osteoporosis, Joint Bone Spine, vol.79, issue.1, pp.26-31, 2012. ,
DOI : 10.1016/j.jbspin.2011.05.004
Ost??odensitom??trie??: principes et indications, Progr??s en Urologie - FMC, vol.20, issue.4, pp.119-141, 2010. ,
DOI : 10.1016/j.fpurol.2010.05.003
Densitometrie : indications, technique, resultats, controle de qualite, Journal de Radiologie, vol.89, issue.10, p.1257, 2008. ,
DOI : 10.1016/S0221-0363(08)75744-5
accréditation et d'évaluation en santé Diagnostic de l'ostéoporose en rhumatologie chez les femmes ménopausées ,
Ost??oporoses??: g??n??ralit??s, strat??gie diagnostique, EMC - Appareil locomoteur, vol.7, issue.2, pp.1-5, 2012. ,
DOI : 10.1016/S0246-0521(12)51756-0
Official Positions of the International Society for Clinical Densitometry, The Journal of Clinical Endocrinology & Metabolism, vol.89, issue.8, pp.3651-3656, 2004. ,
DOI : 10.1210/jc.2004-0124
Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial, JAMA, vol.288, pp.321-354, 2002. ,
FRAX??? and the assessment of fracture probability in men and women from the UK, Osteoporosis International, vol.17, issue.Suppl 2, pp.385-97, 2008. ,
DOI : 10.1007/s00198-007-0543-5
Optimal use of FRAX??, Joint Bone Spine, vol.76, issue.1, pp.1-3, 2009. ,
DOI : 10.1016/j.jbspin.2008.11.001
URL : https://hal.archives-ouvertes.fr/inserm-00395611
Evaluation of the calcium content of diet by frequential self-questionnaire, Rev Rhum Mal Osteoartic, vol.58, pp.99-103, 1991. ,
Has reimbursement of bone mineral density testing and anti-osteoporotic treatments improved management of osteoporosis in France?, Bone, vol.47, issue.4, pp.790-794, 2010. ,
DOI : 10.1016/j.bone.2010.06.026
Apparent Pre- and Postmenopausal Bone Loss Evaluated by DXA at Different Skeletal Sites in Women: The OFELY Cohort, Journal of Bone and Mineral Research, vol.8, issue.suppl 1, pp.683-90, 1997. ,
DOI : 10.1359/jbmr.1997.12.4.683
Calcium intake and the risk of osteoporosis and fractures in French women, Joint Bone Spine, vol.77, issue.2, pp.154-162, 2010. ,
DOI : 10.1016/j.jbspin.2009.08.007
D??pistage d'une ost??oporose chez??200??femmes m??nopaus??es ayant une??fracture p??riph??rique non f??morale, Revue du Rhumatisme, vol.74, issue.10-11, pp.1070-1071, 2007. ,
DOI : 10.1016/j.rhum.2007.10.081
Prevalence and features of osteoporosis in the French general population: The Instant study, Joint Bone Spine, vol.76, pp.394-400, 2009. ,
??valuation de la pratique des m??decins g??n??ralistes pour le d??pistage et le traitement de l???ost??oporose chez les femmes de 60ans et plus, Revue du Rhumatisme, vol.80, issue.6, pp.594-602, 2013. ,
DOI : 10.1016/j.rhum.2013.02.004
Évaluation des pratiques professionnelles. À propos de la prescription de l'ostéodensitométrie chez la femme ménopausée, Rev Rhum, vol.77, pp.643-650, 2010. ,
accréditation et d'évaluation en santé Agence Française de la sécurité sanitaire des produits de santé. Traitements hormonaux substitutifs de la ménopause -Argumentaire. Mis à jour le 11 mai, Disponible sur http, 2004. ,
Prevalence of risk factors for referring post-menopausal women for bone densitometry. The INSTANT study, Joint Bone Spine, vol.75, issue.6, pp.702-78, 2008. ,
DOI : 10.1016/j.jbspin.2007.12.007
Estimated number of women likely to benefit from bone mineral density measurement in France, Joint Bone Spine, vol.71, issue.5, pp.409-427, 2004. ,
DOI : 10.1016/j.jbspin.2003.11.007
URL : https://hal.archives-ouvertes.fr/inserm-00168648
A meta-analysis of the effects of cigarette smoking on bone mineral density, Calcified Tissue International, vol.48, issue.2A, pp.259-70, 2001. ,
DOI : 10.1007/BF02390832
Vitamin and Mineral Inadequacy in the French Population: Estimation and Application for the Optimization of Food Fortification, International Journal for Vitamin and Nutrition Research, vol.76, issue.6, pp.343-51, 2006. ,
DOI : 10.1024/0300-9831.76.6.343
Utilité clinique du dosage de la vitamine D. Mis en ligne le 30 octobre 2013. [En ligne]. Disponible sur http ,
Meinungen und Einstellungen ??sterreichischer Allgemeinmedizinerinnen und Allgemeinmediziner zu Osteoporose, Wiener Medizinische Wochenschrift, vol.34, issue.10 Suppl, pp.247-52, 2009. ,
DOI : 10.1007/s10354-009-0648-x
Osteoporosis screening and treatment guidelines, Menopause, vol.18, issue.10, pp.1072-1080, 2011. ,
DOI : 10.1097/gme.0b013e318215101a
Prevalence of risk factors for fractures and use of DXA scanning in Danish women. A regional population-based study, Osteoporosis International, vol.20, issue.5, pp.1401-1410, 2011. ,
DOI : 10.1007/s00198-010-1348-5
Are osteoporotic fractures being adequately investigated?: A questionnaire of GP & orthopaedic surgeons, BMC Family Practice, vol.103, issue.5, p.7, 2006. ,
DOI : 10.3109/03009749609103753
Doctors??? beliefs and knowledge on corticosteroid-induced osteoporosis: identifying barriers to improve prevention, Journal of Clinical Pharmacy and Therapeutics, vol.116, issue.5 Suppl., pp.356-66, 2011. ,
DOI : 10.1111/j.1365-2710.2010.01185.x
Population-Based Trends in Osteoporosis Management after New Initiations of Long-Term Systemic Glucocorticoids (1998???2008), The Journal of Clinical Endocrinology & Metabolism, vol.97, issue.4, pp.1236-1278, 1998. ,
DOI : 10.1210/jc.2011-2645
Population Trends in BMD Testing, Treatment, and Hip and Wrist Fracture Rates: Are the Hip Fracture Projections Wrong?, Journal of Bone and Mineral Research, vol.57, issue.S1, pp.898-905, 2005. ,
DOI : 10.1359/JBMR.041231
A Randomized Trial of Letrozole in Postmenopausal Women after Five Years of Tamoxifen Therapy for Early-Stage Breast Cancer, New England Journal of Medicine, vol.349, issue.19, pp.1793-1802, 2003. ,
DOI : 10.1056/NEJMoa032312
Randomized Trial of Letrozole Following Tamoxifen as Extended Adjuvant Therapy in Receptor-Positive Breast Cancer: Updated Findings from NCIC CTG MA.17, JNCI Journal of the National Cancer Institute, vol.97, issue.17, pp.1262-71, 2005. ,
DOI : 10.1093/jnci/dji250
A Randomized Trial of Exemestane after Two to Three Years of Tamoxifen Therapy in Postmenopausal Women with Primary Breast Cancer, New England Journal of Medicine, vol.350, issue.11, pp.1081-92, 2004. ,
DOI : 10.1056/NEJMoa040331
Anastrozole alone or in combination with tamoxifen versus tamoxifen alone for adjuvant treatment of postmenopausal women with early breast cancer: first results of the ATAC randomised trial, Lancet, vol.359, pp.2131-2140, 2002. ,
Alone or in Combination) trial after completion of 5 years' adjuvant treatment for breast cancer, of the ATAC Lancet, vol.365, pp.60-62, 2005. ,
Skeletal effects of exemestane on bone-mineral density, bone biomarkers, and fracture incidence in postmenopausal women with early breast cancer participating in the Intergroup Exemestane Study (IES): a randomised controlled study, The Lancet Oncology, vol.8, issue.2, pp.119-146, 2007. ,
DOI : 10.1016/S1470-2045(07)70003-7
Alone or in Combination (ATAC) Trialists' Group Effect of anastrozole and tamoxifen as adjuvant treatment for early-stage breast cancer: 100-month analysis of the ATAC trial, Lancet Oncol, vol.9, pp.45-53, 2008. ,
Survival and safety of exemestane versus tamoxifen after 2???3 years' tamoxifen treatment (Intergroup Exemestane Study): a randomised controlled trial, The Lancet, vol.369, issue.9561, pp.559-70, 2007. ,
DOI : 10.1016/S0140-6736(07)60200-1
A comparison of letrozole and tamoxifen in postmenopausal women with early breast cancer, N Engl J Med, vol.353, pp.2747-57, 2005. ,
Traitements hormonaux adjuvants des cancers du sein. [En ligne]. Disponible sur http ,
Identification of Osteopenic Women at High Risk of Fracture: The OFELY Study, Journal of Bone and Mineral Research, vol.18, issue.Suppl 6, pp.1813-1822, 2005. ,
DOI : 10.1359/JBMR.050609
Calcium supplementation on bone loss in postmenopausal women, Cochrane Database Syst Rev, 2004. ,
Use of calcium or calcium in combination with vitamin D supplementation to prevent fractures and bone loss in people aged 50 years and older: a meta-analysis, The Lancet, vol.370, issue.9588, pp.657-66, 2007. ,
DOI : 10.1016/S0140-6736(07)61342-7
Ostéopénie: la fin d'une méprise, La Lettre du Rhumatologue, vol.391, pp.31-33, 2013. ,
Initiation of Osteoporosis Treatment after Bone Mineral Density Testing, Osteoporosis International, vol.12, issue.5, pp.337-379, 2001. ,
DOI : 10.1007/s001980170099
Access to Osteoporosis Treatment is Critically Linked to Access to Dual-Energy X-ray Absorptiometry Testing, Medical Care, vol.45, issue.9, pp.896-901, 2007. ,
DOI : 10.1097/MLR.0b013e318054689f